ÂÜÀòÂÒÂ×

Alexandre Fabre has over a decade of proven track record of working in all areas of financial planning, accounting, tax planning, and corporate finance in the biotechnology sector. His expertise includes IFRS accounting, French Gaap, and French Research Tax Credit (CIR). Reporting to the CEO, Mr. Fabre has the day-to-day responsibility for planning, implementing, managing, and controlling all financial-related and operational activities of the company including direct responsibility for accounting, finance, forecasting, strategic planning, and costs.

Previously, Mr. Fabre spent close to eight years at KPMG working across multiple aspects of the finance and accounting functions. He was responsible for internal financial control at Therachon and assisted the company in financial tasks up to the company’s acquisition in 2019. Mr. Fabre graduated with an Accounting and Management Degree from the University of Nice Sophia Antipolis, France.